The orexin-1 receptor antagonist SB-334867 attenuates anxiety in rats exposed to cat odor but not the elevated plus maze: An investigation of Trial 1 and Trial 2 effects

Hormones and Behavior

Volumn 65, Issue 3, 2014, Pages 294-300

  Staples, Lauren G ^a   Cornish, Jennifer L ^a  

^a MACQUARIE UNIVERSITY   (Australia)

Author keywords

Anxiety; Elevated plus maze; Hypocretins; One trial tolerance; Orexins; Predator odor avoidance; SB 334867

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; 1-(2-METHYLBENZOXAZOL-6-YL)-3-(1,5)NAPHTHYRIDIN-4-YL UREA; BENZOXAZOLE DERIVATIVE; OREXIN RECEPTOR; UREA;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; ELEVATED PLUS MAZE TEST; EVOKED RESPONSE; EXPLORATORY BEHAVIOR; LOCOMOTION; MALE; NONHUMAN; OLFACTORY DISCRIMINATION; PRIORITY JOURNAL; RAT; ANALOGS AND DERIVATIVES; ANIMAL; ANIMAL BEHAVIOR; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; DRUG THERAPY; ETIOLOGY; MAZE TEST; MENTAL STRESS; ODOR; PHYSIOLOGY; RECOGNITION; WISTAR RAT;

ANIMALS; ANXIETY; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BENZOXAZOLES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MAZE LEARNING; ODORS; OREXIN RECEPTORS; RATS; RATS, WISTAR; RECOGNITION (PSYCHOLOGY); STRESS, PSYCHOLOGICAL; UREA;

EID: 84896834883     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2013.12.014     Document Type: Article

References (49)

1. Berridge C.W., EspaÒa R.A., Vittoz N.M. Hypocretin/orexin in arousal and stress. Brain Res. 2010, 1314:91-102.
2. Blanchard D.C., Griebel G., Pobbe R., Blanchard R.J. Risk assessment as an evolved threat detection and analysis process. Neurosci. Biobehav. Rev. 2011, 35(4):991-998.
3. Boschen K., Fadel J., Burk J. Systemic and intrabasalis administration of the orexin-1 receptor antagonist, SB-334867, disrupts attentional performance in rats. Psychopharmacology 2009, 206(2):205-213.
4. Boutrel B., Kenny P.J., Specio S.E., Martin-Fardon R., Markou A., Koob G.F., de Lecea L. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(52):19168-19173.
5. Boutrel B., Cannella N., de Lecea L. The role of hypocretin in driving arousal and goal-oriented behaviors. Brain Res. 2010, 1314:103-111.
6. Canteras N.S. The medial hypothalamic defensive system: hodological organization and functional implications. Pharmacol. Biochem. Behav. 2002, 71(3):481-491.
7. Carobrez A.P., Bertoglio L.J. Ethological and temporal analyses of anxiety-like behavior: the elevated plus maze model 20years on. Neurosci. Biobehav. Rev. 2005, 29:1193-1205.
8. Date Y., Ueta Y., Yamashita H., Yamaguchi H., Matsukura S., Kangawa K., Sakurai T., Masashi Y., Nakazato M. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc. Natl. Acad. Sci. U. S. A. 1999, 96(2):748-753.
9. Duncan G.E., Knapp D.J., Breese G.R. Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety. Brain Res. 1996, 713(1-2):79-91.
10. de Lecea L., Kilduff T.S., Peyron C., Gao X.-B., Foye P.E., Danielson P.E., Fukuhara C., Battenberg E.L.F., Gautvik V.T., Bartlett F.S., Frankel W.N., van den Pol A.N., Bloom F.E., Gautvik K.M., Sutcliffe J.G. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. 1998, 95(1):322-327.
11. Dielenberg R.A., Hunt G.E., McGregor I.S. 'When a rat smells a cat': the distribution of Fos immunoreactivity in rat brain following exposure to a predatory odor. Neuroscience 2001, 104(4):1085-1097.
12. Espana R.A., Valentino R.J., Berridge C.W. Fos immunoreactivity in hypocretin-synthesizing and hypocretin-1 receptor-expressing neurons: effects of diurnal and nocturnal spontaneous waking, stress and hypocretin-1 administration. Neuroscience 2003, 121(1):201-217.
13. Fadel J., Burk J.A. Orexin/hypocretin modulation of the basal forebrain cholinergic system: Role in attention. Brain Res. 2010, 1314:112-123.
14. File S.E. The interplay of learning and anxiety in the elevated plus-maze. Behav. Brain Res. 1993, 58(1-2):199-202.
15. Furlong T.M., Vianna D.M.L., Liu L., Carrive P. Hypocretin/orexin contributes to the expression of some but not all forms of stress and arousal. Eur. J. Neurosci. 2009, 30(8):1603-1614.
16. Hagan J.J., Leslie R.A., Patel S., Evans M.L., Wattam T.A., Holmes S., Benham C.D., Taylor S.G., Routledge C., Hemmati P., Munton R.P., Ashmeade T.E., Shah A.S., Hatcher J.P., Hatcher P.D., Jones D.N.C., Smith M.I., Piper D.C., Hunter A.J., Porter R.A., Upton N. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl. Acad. Sci. U. S. A. 1999, 96(19):10911-10916.
17. Harris G.C., Aston-Jones G. Arousal and reward: a dichotomy in orexin function. Trends Neurosci. 2006, 29(10):571-577.
18. Ida T., Nakahara K., Murakami T., Hanada R., Nakazato M., Murakami N. Possible involvement of orexin in the stress reaction in rats. Biochem. Biophys. Res. Commun. 2000, 270(1):318-323.
19. Johnson P.L., Truitt W., Fitz S.D., Minick P.E., Dietrich A., Sanghani S., Traskman-Bendz L., Goddard A.W., Brundin L., Shekhar A. A key role for orexin in panic anxiety. Nat. Med. 2010, 16(1):111-115.
20. Johnson P.L., Samuels B.C., Fitz S.D., Federici L.M., Hammes N., Early M.C., Truitt W., Lowry C.A., Shekhar A. Orexin 1 receptors are a novel target to modulate panic responses and the panic brain network. Physiol. Behav. 2012, 107(5):733-742.
21. Kayaba Y., Nakamura A., Kasuya Y., Ohuchi T., Yanagisawa M., Komuro I., Fukuda Y., Kuwaki T. Attenuated defense response and low basal blood pressure in orexin knockout mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 285(3):R581-R593.
22. Kuwaki T. Orexin links emotional stress to autonomic functions. Auton. Neurosci. 2011, 161(1-2):20-27.
23. Li Y., Li S., Wei C., Wang H., Sui N., Kirouac G. Orexins in the paraventricular nucleus of the thalamus mediate anxiety-like responses in rats. Psychopharmacology 2010, 212(2):251-265.
24. Lungwitz E.A., Molosh A., Johnson P.L., Harvey B.P., Dirks R.C., Dietrich A., Minick P., Shekhar A., Truitt W.A. Orexin-A induces anxiety-like behavior through interactions with glutamatergic receptors in the bed nucleus of the stria terminalis of rats. Physiol. Behav. 2012, 107(5):726-732.
25. Marcus J.N., Aschkenasi C.J., Lee C.E., Chemelli R.M., Saper C.B., Yanagisawa M., Elmquist J.K. Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol. 2001, 435(1):6-25.
26. McGregor I.S., Dielenberg R.A. Differential anxiolytic efficacy of a benzodiazepine on first versus second exposure to a predatory odor in rats. Psychopharmacology 1999, 147:174-181.
27. McGregor I.S., Hargreaves G.A., Apfelbach R., Hunt G.E. Neural correlates of cat odor-induced anxiety in rats: region-specific effects of the benzodiazepine midazolam. J. Neurosci. 2004, 24(17):4134-4144.
28. Mileykovskiy B.Y., Kiyashchenko L.I., Siegel J.M. Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron 2005, 46(5):787-798.
29. Nollet M., Gaillard P., Minier F., Tanti A., Belzung C., Leman S. Activation of orexin neurons in dorsomedial/perifornical hypothalamus and antidepressant reversal in a rodent model of depression. Neuropharmacology 2011, 61(1-2):336-346.
30. Panhelainen A., Korpi E. Evidence for a role of inhibition of orexinergic neurons in the anxiolytic and sedative effects of diazepam: A c-Fos study. Pharmacol. Biochem. Behav. 2012, 101(1):115-124.
31. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., Kilduff T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 1998, 18(23):9996-10015.
32. Sakamoto F., Yamada S., Ueta Y. Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons. Regul. Pept. 2004, 118(3):183-191.
33. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., Arch J.R.S., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.-S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and g protein-coupled receptors that regulate feeding behavior. Cell 1998, 92(4):573-585.
34. Samson W.K., Bagley S.L., Ferguson A.V., White M.M. Hypocretin/orexin type 1 receptor in brain: role in cardiovascular control and the neuroendocrine response to immobilization stress. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 292(1):R382-R387.
35. Shibata M., Mondal M.S., Date Y., Nakazato M., Suzuki H., Ueta Y. Distribution of orexins-containing fibers and contents of orexins in the rat olfactory bulb. Neurosci. Res. 2008, 61(1):99-105.
36. Silveira M., Sandner G., Graeff F. Induction of Fos immunoreactivity in the brain by exposure to the elevated plus maze. Behav. Brain Res. 1993, 56(1):115-118.
37. Singareddy R., Uhde T., Commissaris R. Differential effects of hypocretins on noise-alone versus potentiated startle responses. Physiol. Behav. 2006, 89:650-655.
38. Smart D., Jerman J.C. The physiology and pharmacology of the orexins. Pharmacol. Ther. 2002, 94(1-2):51-61.
39. Soya S., Shoji H., Hasegawa E., Hondo M., Miyakawa T., Yanagisawa M., Mieda M., Sakurai T. Orexin receptor-1 in the locus coeruleus plays an important role in cue-dependent fear memory consolidation. J. Neurosci. 2013, 33(36):14549-14557.
40. Staples L.G. Predator odor avoidance as a rodent model of anxiety: learning-mediated consequences beyond the initial exposure. Neurobiol. Learn. Mem. 2010, 94(4):435-445.
41. Staples L.G., McGregor I.S. Defensive responses of Wistar and Sprague-Dawley rats to cat odour and TMT. Behav. Brain Res. 2006, 172(2):351-354.
42. Staples L.G., Hunt G.E., Cornish J.L., McGregor I.S. Neural activation during cat odor-induced conditioned fear and 'trial 2' fear in rats. Neurosci. Biobehav. Rev. 2005, 29(8):1265-1277.
43. Staples L.G., McGregor I.S., Apfelbach R., Hunt G.E. Cat odor, but not trimethylthiazoline (fox odor), activates accessory olfactory and defense-related brain regions in rats. Neuroscience 2008, 151(4):937-947.
44. Staples L.G., McGregor I.S., Hunt G.E. Long-lasting FosB/[Delta]FosB immunoreactivity in the rat brain after repeated cat odor exposure. Neurosci. Lett. 2009, 462(2):157-161.
45. Steiner M., Lecourt H., Jenck F. The brain orexin system and almorexant in fear-conditioned startle reactions in the rat. Psychopharmacology 2012, 223(4):465-475.
46. Suzuki M., Beuckmann C.T., Shikata K., Ogura H., Sawai T. Orexin-A (hypocretin-1) is possibly involved in generation of anxiety-like behavior. Brain Res. 2005, 1044(1):116-121.
47. Takahashi L.K., Nakashima B.R., Hong H., Watanabe K. The smell of danger: a behavioral and neural analysis of predator odor-induced fear. Neurosci. Biobehav. Rev. 2005, 29(8):1157-1167.
48. Walf A., Frye C. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat. Protoc. 2007, 2:322-328.
49. Winsky-Sommerer R., Yamanaka A., Diano S., Borok E., Roberts A.J., Sakurai T., Kilduff T.S., Horvath T.L., de Lecea L. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): A novel circuit mediating stress response. J. Neurosci. 2004, 24(50):11439-11448.